Fundraising Fox
Glyphic Biotechnologies
Berkeley, US · Founded 2021 · Delaware corporation · 35 employees on LinkedIn · 14 known investors
Find your way into Glyphic Biotechnologies
Each arrow is one introduction. Sign up to fill in the first one.
Ask Helen Liang to introduce you to Daniel Estandian
You →Helen · together at Glyphic Biotechnologies →Daniel
Ask Jamie Chen to introduce you to Josh Yang
You →Jamie · together at Glyphic Biotechnologies →Josh
Sign up to find every way you can get introduced to Glyphic Biotechnologies
- Your email: who you already know at Glyphic Biotechnologies, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Glyphic Biotechnologies team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity. The platform serves research and therapeutic development in proteomics and drug discovery.
Founders & leadership
Glyphic Biotechnologies was founded in 2021 by Daniel Estandian, Ed Boyden, and Josh Yang.
Board
Investors · 14
How we know: Artis Ventures's portfolio page · Not right? Tell us
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: FoundersX Ventures's portfolio page · Not right? Tell us
How we know: Harpoon Ventures's portfolio page · Not right? Tell us
How we know: Modi Ventures's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: oup.vc · Not right? Tell us
How we know: Valor Equity Partners's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$33.2M disclosed across 1 round · 2024
▶$33.2MraisedFeb 2024 · 37 investors · BiotechnologyRule 506(b)
- Joshua YangExecutive Officer, Director
- Craig AsherDirector
- Jimmy YunDirector
- Daniel EstandianExecutive Officer, Director
- Offering amount
- $52.9M
- Amount sold
- $33.2M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Glyphic Biotechnologies.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $408.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $390.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $359K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $409.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Glyphic Biotechnologies do?
- Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity. The platform serves research and therapeutic development in proteomics and drug discovery.
- Who founded Glyphic Biotechnologies?
- Glyphic Biotechnologies was founded by Daniel Estandian, Ed Boyden, Josh Yang in 2021.
- Who are Glyphic Biotechnologies's investors?
- Glyphic Biotechnologies's investors include Artis Ventures, Black Flag, Civilization Ventures Management, Llc, FoundersX Ventures, Harpoon Ventures, LongeVC, Modi Ventures, OMX Ventures and 6 more.
- How much funding has Glyphic Biotechnologies raised?
- Glyphic Biotechnologies has disclosed $33.2M raised across 1 round.
- Where is Glyphic Biotechnologies headquartered?
- Glyphic Biotechnologies is headquartered in Berkeley, US.